Megan Elizabeth Golightly, MS, CCC-SLP is a
Speech-language Pathologist based in Kittery Point, Maine. Megan Elizabeth Golightly is licensed to practice in Maine (license number SP3128) and her current practice location is
7 School Ln, Kittery Point, Maine. She can be reached at her office (for appointments etc.) via phone at
(207) 439-1707.
NPI number for Megan Elizabeth Golightly is 1821659228 and her current mailing address is 120 Main St Apt 448, Saco, Maine. She
does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1821659228.
Healthcare Provider's Profile
Full Name | Megan Elizabeth Golightly |
---|
Gender | Female |
---|
Speciality | Speech-language Pathologist |
---|
Location | 7 School Ln, Kittery Point, Maine |
---|
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
NPI Data:
- NPI Number: 1821659228
- Provider Enumeration Date: 06/26/2019
- Last Update Date: 12/13/2021
Medical Identifiers
Medical identifiers for Megan Elizabeth Golightly such as npi, medicare ID, medicare PIN, medicaid, etc.
Identifier | Type | State | Issuer |
1821659228 | NPI | - | NPPES |
Medical Taxonomies and Licenses
Taxonomy | Type | License (State) | Status |
235Z00000X | Speech-language Pathologist | SP3128 (Maine) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Megan Elizabeth Golightly is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
Mailing Address | Practice Location Address |
Megan Elizabeth Golightly, MS, CCC-SLP 120 Main St Apt 448, Saco, ME 04072-3547 Ph: (603) 205-5529 | Megan Elizabeth Golightly, MS, CCC-SLP 7 School Ln, Kittery Point, ME 03905-5126 Ph: (207) 439-1707 |
Reviews and Comments